Login to Your Account



Dendreon Buying Corvas For $73M, Growing Cancer Program

By Aaron Lorenzo


Wednesday, February 26, 2003
Dendreon Corp. signed a definitive merger agreement to acquire Corvas International Inc. in a $72.9 million stock transaction that would combine the companies' cancer and cardiovascular pipelines and effectively double Dendreon's cash holdings. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription